期刊文献+

核因子KLF6与PPARγ在大鼠非酒精性脂肪性肝炎中的动态变化 被引量:3

Relationship between PPARγ and KLF6 in nonalcoholic steatohepatitis rat
下载PDF
导出
摘要 目的:研究核转录因子过氧化物酶体增殖物活化受体γ(peroxisome proliferation activated receptor gamma,PPARγ)和核因子KLF6(Kruppule like factor,KLF6)在非酒精性脂肪性肝炎(NASH)大鼠肝纤维化形成过程中的作用及相互关系。方法:高脂饮食建立NASH肝纤维化大鼠模型,HE和Massson染色观察肝组织病理学变化,检测血清AST、ALT、透明质酸(HA)、层粘连蛋白(LN)、Ⅵ型胶原(CⅥ)的动态变化,RT-PCR检测核转录因子KLF6、PPARγ和α-SMA mRNA的动态表达变化。结果:(1)F12~24周肝脏炎症活动度计分较对照组明显增高(P<0.05~0.01)。(2)F16、24周组肝纤维化评分与对照组比较明显升高,差异有统计学意义(P<0.05~0.01)。(3)高脂喂养12周后,血清AST、ALT水平逐步增高,与对照组比较差异有统计学意义(P<0.05~0.01)。随着高脂喂养时间的延长,血清肝纤维化指标HA、LN和CⅣ水平呈逐渐增高趋势,与对照组比较差异有统计学意义(P<0.05~0.01)。(4)RT-PCR显示模型组PPARγmRNA于高脂喂养8周单纯性脂肪肝时即明显上调(0.84±0.07 vs 0.54±0.12,P<0.05),12周达高峰(1.16±0.14),16周脂肪性肝炎明显时表达开始下调(0.73±0.05),24周下调更为明显(0.34±0.15),与对照组比较差异均有统计学意义(P<0.05);而KLF6、α-SMA mRNA于高脂喂养12周开始增高,24周达高峰,与对照组比较差异显著(P<0.01)。(5)相关分析发现,KLF6与α-SMA表达及炎症、肝纤维化分级评分之间呈显著正相关(r=0.859、0.956、0.706,P<0.01),而与PPARγ呈负相关(r=-0.536,P<0.05)。结论:单纯性脂肪肝时,PPARγ的高表达可能是机体的一种适应性反应,从而抑制促炎、促纤维生成因子KLF6的释放,当损伤因素持续存在,损伤与抗损伤动态平衡失调后PPARγ合成减弱,而KLF6则明显增加,激活HSC,共同参与NASH肝纤维化形成过程。 Objective: To study the relation between PPARγ and KLF6 in the development of nonalcoholic steatohepatitis related fibrosis in rats.Methods:Fatty liver fibrosis model of rats was established by high fat feeding.Pathological change of hepatic tissues was observed by HE and Masson staining;dynastic change of AST,ALT,hyaluronic acid(HA),laminin(LN) and collagen Ⅵ(CⅥ) were detected,and expressions of PPARγ,KLF6 and α-SMA were determined by RT-PCR.Results:(1)The score of hepatic inflammatory activity was significantly higher in experimental group than control group during F12-24 weeks(P0.01-0.05).(2) Score of hepatic fibrosis was significantly higher in experimental group than control group at F16 week and 24 weeks(P0.01-0.05).(3) After high fat feeding for 12 weeks,AST and ALT were significantly increased compared with control group(P0.01-0.05).HA,LN and CⅣwere increased as feeding time increased,and there were significant difference compared with control group(P0.01-0.05).(4) RT-PCR showed that the expression of PPARγ mRNA of model group was significance higher as compared with that of rats with the high fat diet for 8 weeks(0.84 ± 0.07 vs.0.54 ± 0.12,P0.05).The peak was achieved at 12th weeks(1.16± 0.14),then decreased gradually at 16th week(0.73±0.05).The decline was more obvious at 24 weeks(0.34±0.15),and there was significant difference between two groups(P0.05).While KLF6、α-SMA mRNA were increased at the 12th week.It achieved the peak at 24th week,and there was significant difference between two groups(P0.05).(5)KLF6 was closely correlated with α-SMA and the scoring of inflammation and hepatic fibrosis(r=0.859,0.956,0.706,P0.01),but had negative correlation with PPARγ(r=-0.536,P0.05).Conclusions:In patients with simple fatty liver,high PPARγ expression is an adaptive response,and can inhibit release of KLF6.With the high fat-induced hepatic injury aggravated,the gradually decreased expression of PPARγ is closely related to the activation of KLF6 and hepatic stellate cells,thereby promote the development of fatty liver fibrosis.
出处 《海南医学院学报》 CAS 2012年第4期452-456,共5页 Journal of Hainan Medical University
基金 中国高校医学期刊临床专项资金项目(11221091)~~
  • 相关文献

参考文献13

  • 1Dowman JK,Tomlinson JW,Newsome PN. Pathogenesis of non-alcoholic fatty liver disease[J].Quarterly Journal of Medicine,2010,(2):71-83.doi:10.1093/qjmed/hcp158.
  • 2周传文,潘峰,李倩君,崔建和,李东海,任建国.L-FABP与非酒精性脂肪肝及胰岛素抵抗的关系[J].实用临床医药杂志,2010,14(10):92-94. 被引量:4
  • 3陈洁,郑瑞丹,徐成润,伍伟平,陈碧芬,陈雪婉,林志辉.大鼠非酒精性脂肪肝病中LXR-α和SREBP-1c表达及罗格列酮的干预研究[J].南方医科大学学报,2009,29(2):346-349. 被引量:6
  • 4Jonathan A. Fallow field therapeutic targets in liver fibrosis[J].American Journal of Physiology-Gastrointestinal and Liver Physiology,2011.G709-G715.
  • 5Yu J,Zhang S,Chu ES. Peroxisome proliferatoractivated receptors gamma reverses hepatic nutritional fibrosis in mice and suppresses activation of hepatic stellate cells in vitro[J].International Journal of Biochemistry & Cell Biology,2010,(06):948-957.doi:10.1016/j.biocel.2010.02.006.
  • 6Kang QH,Chen AP. Curcumin Inhibits srebp-2 epression in activated hepatic stellate cells in vitro by reducing the activity of specificity protein-1[J].Endocrinology,2009,(12):5384-5394.doi:10.1210/en.2009-0517.
  • 7Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量:1511
  • 8Sean WP,Koppe AS,Malladi P. Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet[J].Journal of Hepatology,2004,(04):592-598.doi:10.1016/j.jhep.2004.06.030.
  • 9Lutchman G,Promrat K,David EK. Changes in serum adipokine levels during pioglitazone treatment for nonalcoholic steatohepatitis:relationship to histological Improvement[J].Clinical Gastroenterology and Hepatology,2006,(08):1048-1052.doi:10.1016/j.cgh.2006.05.005.
  • 10Zhou Y,Jia X,Wang G. PI-3 K/AKT and ERK signaling pathways mediate leptin-induced inhibition of PPARgamma gene expression in primary rat hepatic stellate cells[J].Molecular and Cellular Biochemistry,2009,(1-2):131-139.doi:10.1007/s11010-009-0027-3.

二级参考文献31

  • 1胡国平,刘凯,赵连三.多烯磷脂酰胆碱(易善复)治疗酒精性肝病和脂肪肝的系统评价[J].肝脏,2005,10(1):5-7. 被引量:108
  • 2Day CP. Non-alcoholic fatty liver disease: Current concepts and management strategies[J]. Clin Med, 2006, 6(1): 19-25.
  • 3Willy PJ, Umesono K, Ong ES, et al. LXR, a nuclear receptor that defines a distinct retinoid response pathway [ J ]. Genes Dev, 1995, 9 (5): 1033-45.
  • 4Uehara Y, Miura S, von Eckardstein A, et al. ATP-binding cassette transporter G1 (ABCG1) and ABCA1 genes via an LXR/RXR responsive elements[J]. Atherosclerosis, 2007, 191(1): 11-21.
  • 5Jeffrey WC, Jenny H, Scott AM, et al. The LXR ligand T091317 induces severe lipogenesis in the db/db diabetic mouse [J]. J Lipid Res, 2003, 44(11): 2039-48.
  • 6Nakatani T, Katsumata A, Mitura S, et al. Effects of fish oil feeding and fasting on LXR alpha/RXR alpha binding to LXRE in the SREBP-1c promoter in mouse liver [J]. Biochim Biophys Acta, 2005, 1736(1): 77-86.
  • 7Yoshikawa T, Ide T, Shimnao H, et al. Cross-talk between peroxisome prolieffator-aetivated receptor (PPAR) alpha and liver X receptor (LXR) in nurtitional regulation fatty acid metabolism. Ⅰ. PAPRS supperss sterol regulatory element binding .protein-1c promoter through inhibition of LXR singaling [J ]. Mol Endocrinol, 2003, 17(7): 1240-54.
  • 8Tomohiro I, Hitoshi S, Tomohiro Y, et al. Cross-talk between peroxisome proliferator-activated receptor (PPAR) α and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. Ⅱ. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling[J]. Mol Endocriuol, 2003, 17(7): 1255-67.
  • 9Mishkin S,Stein L,Gatmaitan Z,et al.The binding of fatty acids to cytoplasmic proteins:binding to Z protein in liver and other tissues ofthe rat[J].Biochem Biophys Res Commun,1972,47(5):997.
  • 10WangQ,Li H,LiN,et al.Tissue exp ression and association with fat2 ness traits of liver fatty acid2binding protein gene in chicken[J].Poult Sci,2006,85(11):1890.

共引文献1517

同被引文献44

  • 1钱晓武,范竹萍,邱德凯.脂联素及受体与非酒精性脂肪性肝炎[J].国际消化病杂志,2006,26(3):157-160. 被引量:2
  • 2Angulo P.Nonalcoholic fatty liver disease[J].N Engl J Med, 2002,34 (6) : 1221-1231.
  • 3Adams LA, Lindor KD.Nonalcoholic fatty liver disease[J].Ann Epidemi- o1,2007,17(3) :863-869.
  • 4Watanabe S,Yaginuma R,lkejinm K.Liver diseases and metabolic syndrome[J].J Gastroenterol, 2008,43 ( 12 ) : 509-5 ! 8.
  • 5Park KG,Min AK,Koh EH,et aLAlpha-lipoic acid decreases hepatic lipogenesis through adenosine monophosphate-activated protein ki- nase (AMPK)-dependent and AMPK-independent pathways[J].Hep- atology, 2008,48 (3) : 1477-1486.
  • 6Zou Y, Li J,Lu C, Wang J ,et d.High-fa! emulsion-induced rat model of nonalcoholic steatohepatitis[J].Life Sci, 2006,79 (4) : 1100-1107.
  • 7Ascencio C,Torres N,Isoard-Acosta F,et Cd.Soy protein aft cts seruminsulin and hepatic SREBP-1 mRNA and reduces fatty liver in rats[J]. J Nutr,2004,13(4) :522-529.
  • 8Day CP,James OF,Steatohepatitis,et aLA tale of two "hits"[J].Gas- troenterology, 1998,11 (4) :842-845.
  • 9Lin HZ,Yang SQ,Chuckaree C,et a/.Metformin reverses fatty liver disease in obese ,leptin-deficient mice[J].Nat Med ,2000,6 (1):998- 1003.
  • 10Shen B,Yu J,Wang S,et cd.Phyllanthus urinaria ameliorates the severity of nutritional steatohepatitis both in vitro and in vivo[J]. Hepatology, 2008,47 ( 11 ) :473-483.

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部